Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gastrointestinal Stromal Tumors × binimetinib × Clear all

Sponsor

Conditions

Melanoma 12 Colorectal Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Neoplasm Metastasis 5 Neoplasms 4 Lung Neoplasms 4 Brain Neoplasms 4 Skin Neoplasms 2 Skin Diseases 2 Hematologic Neoplasms 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Spinocerebellar Degenerations 1 Solid Tumors Harboring a BRAF V600 Mutation 1 Soft Tissue Neoplasms 1 Peripheral Nervous System Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Noonan Syndrome 5 1 Neurofibromatosis 1 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neurofibroma 1 Multiple Myeloma 1 Lymphoma 1 Lymphatic Metastasis 1 Low-grade Serous Ovarian Cancer 1 Leukemia, Myeloid, Acute 1 Hereditary Sensory and Autonomic Neuropathies 1 Gliosarcoma 1

Interventions

Sunitinib 14 Imatinib Mesylate 12 nilotinib 7 ripretinib 3 regorafenib 3 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 3 pexidartinib 2 pembrolizumab 2 avapritinib 2 Bevacizumab 2 trametinib 1 spartalizumab 1 romidepsin 1 ponatinib 1 pazopanib 1 palbociclib 1 olaratumab 1 guadecitabine 1 ferric carboxymaltose 1 epacadostat 1 dabrafenib 1 cediranib 1 Surveys and Questionnaires 1 Sorafenib 1 Observation 1 Iron-Dextran Complex 1 Indocyanine Green 1 Immunoglobulin G 1 HhAntag691 1 Fluorescein 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡